SEC Form 3 · accession 0001144204-17-044681
AVENUE THERAPEUTICS, INC. · ATXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fortress Biotech, Inc.
10% Owner
Period of report
Mar 13, 2017
Accepted (ET)
Aug 23, 2017 · 10:12 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001644963
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 3,316,259 | D | ||
| Class A Preferred Stock | holding | — | — | — | 250,000 | D |
Table II — derivative securities
No Table II lines on this filing.